Advertisement
Advertisement

MURA

MURA logo

Mural Oncology plc

3.17
USD
-0.22
-6.49%
Dec 18, 15:59 UTC -5
Closed
...

Mural Oncology plc Profile

About

Mural Oncology plc is a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Mural Oncology plc is based in DUBLIN, Ireland.

Info & Links

CEO

Caroline Loew

Headquarters

10 Earlsfort Terrace
Dublin, L2 D02 T380, IRELAND

Auditor

PricewaterhouseCoopers LLP

Share holders

72

Employees

117

Mural Oncology plc Statistics

Valuation Measures

Market Capitalization2

53.95M

Enterprise Value

-57.06M

Enterprise Value/EBITDA(ttm)

0.36

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.36

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-70.10%

Return on Invested Capital(ttm)

-69.39%

Return on Assets(ttm)

-61.30%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-157.66M

Net Income Available to Common(ttm)

-153.78M

Diluted EPS(ttm)

-9.14

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-13.86%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

17.01M

% Held by Insiders

0.06%

% Held by Institutions

80.21%

Balance Sheet

Total Cash(mrq)

175.50M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.38%

Quick Ratio(mrq)

7.38%

Book Value Per Share(mrq)

10.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.68

Free Cash Flow(ytd)

-96.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement